ICascara Sagrada

Umxholo

• Inokwenzeka ukuba isebenze ...
• Kusenokwenzeka ukuba ayisebenzi ...
• Akukho bungqina baneleyo bokulinganisa ukusebenza ...
• Amanyathelo okhuseleko kunye nezilumkiso:

ICascara sagrada sisihlahla. Amaxolo omileyo asetyenziswa ekwenzeni iyeza.

ICascara sagrada yayisoloko ivunyiwe yiU.S.Ukutya kunye noLawulo lweeDrug (i-FDA) njengesiyobisi esingaphaya kwekhawuntare (OTC) sokuqunjelwa. Nangona kunjalo, kule minyaka idlulileyo, iinkxalabo zaphakanyiswa malunga nokhuseleko nokusebenza ngempumelelo kwecascara sagrada. I-FDA inike abavelisi ithuba lokungenisa ulwazi lokhuseleko kunye nokusebenza ukuze baphendule ezi zinto zixhalabisayo. Kodwa iinkampani zigqibe kwelokuba iindleko zokuqhuba izifundo zokhuseleko kunye nokusebenza ngempumelelo kunokuba ngaphezulu kunenzuzo abanokuyilindela kwintengiso yecascara sagrada. Ke abakhange bahambisane nesicelo. Ngenxa yoko, i-FDA yazisa abavelisi ukuba basuse okanye bahlengahlengise zonke iimveliso ze-laxative ze-OTC eziqukethe i-cascara sagrada evela kwimakethi yase-US ngo-Novemba 5, 2002. Namhlanje, ungathenga i-cascara sagrada "njengesongezelelo sokutya", kodwa hayi njengechiza. "Izongezo zokutya" akufuneki zihlangabezane nemigangatho esebenza kuyo i-FDA kwi-OTC okanye kumachiza amiselweyo.

ICascara sagrada ixhaphakileyo isetyenziswa ngumlomo njenge-laxative yokuqhinwa.

Ekutyeni nasekuseleni, ngamanye amaxesha kusetyenziswa i-arhente yecascara sagrada njengearhente yokunambitha.

Kwimveliso, i-cascara sagrada isetyenziselwa ukulungisa ezinye izinto zokuthambisa ilanga.

Amayeza endalo aVimba weDatha Ukusebenza kwexabiso ngokusekwe kubungqina besayensi ngokwala manqanaba alandelayo: Ukusebenza, ukusebenza ngokukuko, okunokwenzeka ukuba kusebenze, okungenzeka kungasebenzi, kunokwenzeka ukungasebenzi, ukungasebenzi, kunye nobungqina obungonelanga bokulinganisa.

Ukulinganiswa kokusebenza kwe ICASCARA SAGRADA zezi zilandelayo:

Inokwenzeka ukuba isebenze ...

• Ukuqunjelwa. I-Cascara sagrada ineempembelelo ze-laxative kwaye inokunceda ekunciphiseni ukuqunjelwa kwabanye abantu.

Kusenokwenzeka ukuba ayisebenzi ...

• Ukuchitha ikholoni ngaphambi kwekolonoscopy. Uninzi lophando lubonisa ukuba ukuthatha i-cascara sagradaalong kunye ne-magnesium sulphate okanye ubisi lwe-magnesia akuphuculi ukucocwa kwamathumbu kubantu abaphantsi kwe-colonoscopy.

Akukho bungqina baneleyo bokulinganisa ukusebenza ...

• Ukuphazamiseka okuchaphazela ukuhamba kwenyongo esibindini njengamatye enyongo.
• Isifo sesibindi.
• Umhlaza.
• Ezinye iimeko.

Ubungqina obungakumbi buyafuneka ukukala ukusebenza kwecascara sagrada kwezi zinto zisetyenziswayo.

ICascara sagrada iqulethe imichiza evuselela amathumbu kwaye inefuthe lokuhambisa isisu.

Xa kuthathwa ngomlomo: ICascara sagrada yiyo UKHUSELEKO OLUNOKWENZEKA kubantu abadala abaninzi xa bethathwe ixesha elingaphantsi kweveki. Iziphumo ebezingalindelekanga zibandakanya ukungahambi kakuhle kwesisu kunye necramp.

ICascara sagrada yiyo OKUNGENZEKA UKHUSELEKILE xa isetyenziswe ngaphezulu kweveki enye. Oku kunokubangela iziphumo ebezingalindelekanga ezimandundu ngakumbi kubandakanya ukuphelelwa ngamanzi emzimbeni; amanqanaba asezantsi e-potassium, isodiyam, i-chloride, kunye nezinye "ii-electrolyte" egazini; iingxaki zentliziyo; ubuthathaka bemisipha; nabanye.

Amanyathelo okhuseleko kunye nezilumkiso:

Ukukhulelwa kunye nokuncancisa: Akukho lwazi lwaneleyo lunokuthenjwa lokwazi ukuba i-cascara sagrada ikhuselekile ukusetyenziswa xa ukhulelwe. Hlala kwicala elikhuselekileyo kwaye uphephe ukusetyenziswa. ICascara sagrada yiyo OKUNGENZEKA UKHUSELEKILE xa uthathwe ngomlomo ngexa uncancisa. ICascara sagrada inokuwela kubisi lwebele kwaye inokubangela urhudo kusana olusancancisayo.

Abantwana: ICascara sagrada yiyo OKUNGENZEKA UKHUSELEKILE ebantwaneni xa uthathwe ngomlomo. Musa ukunika i-cascara sagrada kubantwana. Banokwenzeka ngakumbi kunabantu abadala ukuba baphelelwe ngamanzi emzimbeni kwaye benzakaliswe nelahleko yee-electrolyte, ngakumbi i-potassium.

Ukuphazamiseka kwesisu (GI) njengokuphazamiseka kwamathumbu, isifo seCrohn, isifo sezilonda, ulonda, izilonda zesisu, okanye iintlungu zesisu ezingachazwanga.Abantu abanayo nayiphi na kwezi meko akufuneki basebenzise i-cascara sagrada.

Iphakathi

Lumka ngale nhlanganisela.

I-Digoxin (Lanoxin)

I-Cascara sagrada luhlobo lwe-laxative ebizwa ngokuba yi-laxative evuselelayo. I-laxatives ekhuthazayo inokunciphisa amanqanaba e-potassium emzimbeni. Amanqanaba e-potassium asezantsi anokunyusa umngcipheko weziphumo ebezingalindelekanga ze-digoxin (Lanoxin).

Amayeza odumba (Corticosteroids)

Amanye amayeza wokudumba anokunciphisa i-potassium emzimbeni. ICascara sagrada luhlobo lwe-laxative olunokunciphisa i-potassium emzimbeni. Ukuthatha i-cascara sagrada kunye namanye amayeza okuvuvukala kunokunciphisa i-potassium emzimbeni kakhulu.

Amanye amayeza okuvuvukala aquka i-dexamethasone (i-Decadron), i-hydrocortisone (i-Cortef), i-methylprednisolone (i-Medrol), i-prednisone (i-Deltasone) kunye nabanye.

I-laxatives ekhuthazayo

I-Cascara sagrada luhlobo lwe-laxative ebizwa ngokuba yi-laxative evuselelayo. I-laxatives ezikhuthazayo zikhawulezisa amathumbu. Ukuthatha i-cascara sagrada kunye nezinye i-laxatives ezikhuthazayo kunokukhawulezisa amathumbu kakhulu kwaye kubangele ukomisa emzimbeni kunye neeminerali ezisezantsi emzimbeni.

Ezinye i-laxatives ezikhuthazayo zibandakanya i-bisacodyl (Correctol, Dulcolax), ioyile ye-castor (iPurge), i-senna (iSenokot), kunye nezinye.

IWarfarin (Coumadin)

ICascara sagrada inokusebenza njenge-laxative. Abanye abantu becarcara sagrada banokubangela urhudo. Urhudo lunokunyusa iziphumo ze-warfarin kunye nokunyusa umngcipheko wokopha. Ukuba uthatha i-warfarin, musa ukuthatha izixa ezigqithileyo zecascara.

Iipilisi zamanzi (iziyobisi zeDiuretic)

ICascara sagrada sisiyobisi. Ezinye i-laxatives zinokunciphisa i-potassium emzimbeni. "Iipilisi zamanzi" zinokunciphisa i-potassium emzimbeni. Ukuthatha i-cascara sagrada kunye "neepilisi zamanzi" kunokunciphisa i-potassium emzimbeni kakhulu.

Ezinye "iipilisi zamanzi" ezinokunciphisa i-potassium zibandakanya i-chlorothiazide (Diuril), chlorthalidone (Thalitone), furosemide (Lasix), hydrochlorothiazide (HCTZ, HydroDiuril, Microzide), nezinye.

Ichromium ene-herbs kunye nezongezelelo

ICascara sagrada iqulethe i-chromium kwaye inokunyusa umngcipheko wetyhefu ye-chromium xa ithathwa nge-chromium supplements okanye i-chromium-containing herbs such as bilberry, yewer's brewer, or horsetail.

Amayeza aqukethe i-glycosides yentliziyo

I-glycosides ye-Cardiac ziikhemikhali ezifanayo kumachiza amayeza e-digoxin. I-Cardiac glycosides inokubangela ukuba umzimba uphulukane ne-potassium.

ICascara sagrada nayo inokubangela ukuba umzimba uphulukane ne-potassium kuba yi-laxative evuselelayo. I-laxatives ezikhuthazayo zikhawulezisa amathumbu. Ngenxa yoko, ukutya akunakuhlala emathunjini ixesha elide ngokwaneleyo ukuba umzimba ukwazi ukufunxa izimbiwa ezinje nge potassium. Oku kunokukhokelela ekunciphiseni kunamanqanaba afanelekileyo e-potassium.

Sebenzisa i-cascara sagrada kunye nomfuno oqukethe i-cardiac glycosides kunokubangela ukuba umzimba uphulukane ne-potassium eninzi, kwaye oku kunokubangela ukonakala kwentliziyo. Amayeza aqukethe i-glycosides yentliziyo ibandakanya i-hellebore emnyama, iingcambu ze-hemp zaseCanada, igqabi ledigitalis, isardard yehadge, figwort, inyibiba yeengcambu zentlambo, i-motherwort, igqabi le-oleander, isityalo semehlo le-pheasant, ingcambu ye-pleurisy, isikali segqabi le-bulb, inkwenkwezi yaseBhetelehem, imbewu ye strophanthus , kunye no-uzara. Gwema ukusebenzisa i-cascara sagrada ngayo nayiphi na kwezi.

Ukuthengiswa kwehashe

IHorsetail inyusa imveliso yomchamo (isebenza njenge-diuretic) kwaye oku kunokubangela ukuba umzimba uphulukane ne-potassium.

ICascara sagrada inokubangela ukuba umzimba uphulukane ne-potassium kuba isisu esivuselelayo. I-laxatives ezikhuthazayo zikhawulezisa amathumbu. Ngenxa yoko, ukutya akunakuhlala emathunjini ixesha elide ngokwaneleyo ukuba umzimba ukwazi ukufunxa izimbiwa ezinje nge potassium. Oku kunokukhokelela ekunciphiseni kunamanqanaba afanelekileyo e-potassium.

Ukuba amanqanaba e-potassium ehla kakhulu, intliziyo inokulimala. Kukho inkxalabo yokuba ukusebenzisa i-horsetail kunye ne-cascara sagrada kwandisa umngcipheko wokuphulukana ne-potassium eninzi kwaye kwandisa umngcipheko wokonzakala kwentliziyo. Gwema ukusebenzisa i-cascara sagrada ngehasheetail.

Licorice

Ilayisensi ibangela ukuba umzimba uphulukane ne potassium.

ICascara sagrada nayo inokubangela ukuba umzimba uphulukane ne-potassium kuba yi-laxative evuselelayo. I-laxatives ezikhuthazayo zikhawulezisa amathumbu. Ngenxa yoko, ukutya akunakuhlala emathunjini ixesha elide ngokwaneleyo ukuba umzimba ukwazi ukufunxa izimbiwa ezinje nge potassium. Oku kunokukhokelela ekunciphiseni kunamanqanaba afanelekileyo e-potassium.

Ukuba amanqanaba e-potassium ehla kakhulu, intliziyo inokulimala. Kukho inkxalabo yokuba ukusebenzisa i-licorice kunye ne-cascara sagrada kwandisa umngcipheko wokuphulukana ne-potassium eninzi kwaye inyuse umngcipheko wokonzakala kwentliziyo. Kulumkele ukusebenzisa i-cascara sagrada ene-licorice.

Imifuno yokuvuselela isisu

ICascara sagrada sisiyobisi esishukumisayo. I-laxatives ezikhuthazayo zikhawulezisa amathumbu. Ngenxa yoko, ukutya akunakuhlala emathunjini ixesha elide ngokwaneleyo ukuba umzimba ukwazi ukufunxa izimbiwa ezinje nge potassium. Oku kunokukhokelela ekunciphiseni kunamanqanaba afanelekileyo e-potassium.

Kukho inkxalabo yokuba ukuthatha i-cascara sagrada kunye namanye amayeza e-laxatives akhuthazayo angenza amanqanaba e-potassium ehle kakhulu, kwaye oku kungonakalisa intliziyo. Amanye amayeza e-laxative avuselelayo yialoe, alder buckthorn, ingcambu emnyama, iflegi eblue, ibutternut bark, colocynth, i-buckthorn yaseYurophu, i-fo ti, i-gamboge, i-gossypol, i-bindweed enkulu, i-jalap, imana, ingcambu ye-scammony yaseMexico, i-rhubarb, i-senna kunye ne-dock etyheli. Gwema ukusebenzisa i-cascara sagrada ngayo nayiphi na kwezi.

Akukho kunxibelelana kwaziwayo nokutya.

Idosi efanelekileyo yesarcada sagrada ixhomekeke kwizinto ezininzi ezinje ngeminyaka yomsebenzisi, impilo, kunye nezinye iimeko. Ngeli xesha akukho lwazi lwaneleyo lwesayensi ukumisela uluhlu olufanelekileyo lweedosi ze-cascara sagrada. Gcina ukhumbula ukuba iimveliso zendalo azisoloko zikhuselekile kwaye iidosi zibalulekile. Qiniseka ukuba ulandela umkhombandlela ofanelekileyo kwiilebheli zemveliso kwaye uqhagamshelane nosokhemesti okanye ugqirha okanye olunye uqeqesho kwezempilo ngaphambi kokusebenzisa. Aulne Noir, Bitter Bark, Bois Noir, Bois à Poudre, Borzène, Bourgène, Buckthorn, California Buckthorn, Cáscara, Cascara Sagrada, Chittem Bark, Dogwood Bark, Écorce Sacrée, Frangula purshiana, Nerprun, Pastel Bourexhi, Purshi , Rhamnus purshiana, Rhubarbe des Paysans, Bark Engcwele, Sagrada Bark, Bark Yellow.

Ukuze ufunde okungakumbi malunga nokubhalwa kweli nqaku, nceda ubone Amayeza endalo aVimba weDatha indlela yokusebenza.

1. UCirillo C, uCapasso R.Ukuqunjelwa kunye namayeza ezityalo: umbono. UPhytother Res 2015; 29: 1488-93. Jonga i-abstract.
2. I-Nakasone ES, iTokeshi J.Ukufumanisa okufumanekayo: imeko ye-cholangiocarcinoma echongiweyo ngesahluko emva kokulimala kwesibindi ngenxa yokungenisa kwecascara sagrada. IHawaii J Med yezeMpilo yoLuntu ngo-2015; 74: 200-2. Jonga i-abstract.
3. U-Chang, L. C., Sheu, H. M., Huang, Y. S., Tsai, T. R., no Kuo, K. W. Umsebenzi wenoveli we-emodin: ukuphucula ukulungiswa kwe-nucleotide yokulungiswa kwe-UV- kunye ne-cisplatin-eyenze umonakalo we-DNA kwiiseli zabantu. Biochem Pharmacol 1999; 58: 49-57.
4. Chang, C. J., Ashendel, C. L., Geahlen, R. L., McLaughlin, J. L., kunye namanzi, D. J. Oncogene uphawu lokuhambisa inhibitors ezivela kwizityalo zonyango. KwiVivo 1996; 10: 185-190.
5. U-Chen, H. C., Hsieh, W. T., Chang, W., no-Chung, u-J.G.Aloe-emodin ubangele in vitro G2 / M ukubanjwa komjikelo weseli kwi-promyelocytic leukemia HL-60 iiseli. Ukutya iChem Toxicol 2004; 42: 1251-1257.
6. UPetticrew, M., Watt, I., kunye noSheldon, T. Ukuphononongwa ngokuchanekileyo kokusebenza kwe-laxatives kubantu abadala. Uvavanyo lweTekhnoloji yezeMpilo. Ngo-1997; 1: i-52. Jonga i-abstract.
7. I-Tramonte, S. M., Brand, M. B., Mulrow, C. D., Amato, M. G., O'Keefe, M. E., kunye noRamirez, G. Unyango lokuqhinwa okungapheliyo kubantu abadala. Uphengululo lwenkqubo. J Gen. Ngaphakathi. 1997; 12: 15-24. Jonga i-abstract.
8. UMereto, E., Ghia, M., noBrambilla, G. Uvavanyo lwezinto ezinokubangela i-carcinogenic ye-Senna kunye ne-Cascara glycosides yekolon yeerat. Umhlaza Lett 3-19-1996; 101: 79-83. Jonga i-abstract.
9. USilberstein, E. B., Fernandez-Ulloa, M., kunye neHolo, J. Ngaba ii-cathartics zomlomo zexabiso ekuphuculeni i-gallium scan? Unxibelelwano olufutshane. J Nucl. Medi 1981; 22: 424-427. Jonga i-abstract.
10. UMarchesi, M., Marcato, M., kunye noSilvestrini, C. [Amava onyango kunye nolungiselelo oluqukethe i-cascara sagrada kunye ne-boldo kunyango lokuqhinwa okulula kubantu abadala]. Glin, Mat. Ngo-1982; 63 (11-12): 850-863. Jonga i-abstract.
11. Ifolokhwe, F., Ekberg, O., Nilsson, G., Rerup, C., kunye no Skinhoj, A. Iirejimeni zokucoca. Isifundo seklinikhi kwizigulana ezili-1200. Indawo yesisu. Ngo-1982; 7: 383-389. Jonga i-abstract.
12. UNovetsky, G. J., Turner, D. A., Ali, A., Raynor, W. J., Jr., kunye noFordham, E. W. Ukucoca ikholoni kwi-gallium-67 scintigraphy: ukuthelekiswa okunokwenzeka kweerejimeni. I-AJR Am J Roentgenol. Ngo-1981; 137: 979-981. Jonga i-abstract.
13. I-Stern, F.H.Ukuqunjelwa-luphawu ndawo yonke: isiphumo sokulungiselela esiqulathe ukugxila kwe-Prune kunye necascarin. J NdinguGeriatr Soc 1966; 14: 1153-1155. Jonga i-abstract.
14. UHangartner, P.J, Munch, R., Meier, J., Ammann, R., noBuhler, H. Ukuthelekiswa kweendlela ezintathu zokucoca ikholoni: kuvavanyo lwetyala elingenamsebenzi kunye nezigulana ezingama-300 ezihamba. I-Endoscopy 1989; 21: 272-275. Jonga i-abstract.
15. UPhillip, J., Schubert, G. E., Thiel, A., kunye neWolters, U.[Ukulungiselela i-colonoscopy usebenzisa iGolytely - indlela eqinisekileyo? Uthelekiso lwesifundo sembali kunye nonyango phakathi kokuhlanjwa kwetyuwa kunye neyeza elinetyuwa]. IMed Klin (eMunich) 7-15-1990; 85: 415-420. Jonga i-abstract.
16. Borkje, B., Pedersen, R., Lund, G. M., Enehaug, J. S., kunye noBerstad, A. Ukusebenza kunye nokwamkelwa kweerejimeni ezintathu zokucoca amathumbu. IScand J Gastroenterol 1991; 26: 162-166. Jonga i-abstract.
17. U-Huang, Q., Shen, H. M., kunye no-Ong, uC. Biochem Pharmacol 7-15-2004; 68: 361-371. Jonga i-abstract.
18. Liu, J. B., Gao, X. G., Lian, T., Zhao, A. Z., kunye no-Li, K. Z. [Apoptosis ye-hepatoma HepG2 yeeseli ezibangelwa yi-emodin in vitro]. Zheng. Ngo-2003; 22: 1280-1283. Jonga i-abstract.
19. I-Lai, GH, Zhang, Z., kunye ne-Sirica, i-AE Celecoxib isebenza ngendlela ye-cyclooxygenase-2-ezimeleyo kunye ne-synergy ne-emodin yokucinezela ukukhula kwe-rat cholangiocarcinoma kwi-vitro ngokusebenzisa umatshini obandakanya ukuphucula ukusebenza kwe-Akt kunye nokunyusa ukusebenza kwecaspases-9 kunye -3. Mol. Umhlaza Ther 2003; 2: 265-271. Jonga i-abstract.
20. I-Chen, YC, Shen, SC, Lee, WR, Hsu, FL, Lin, HY, Ko, CH, kunye neTseng, SW Emodin induces apoptosis in promyeloleukemic human HL-60 iiseli ezihamba kunye nokusebenza kwecaspase 3 cascade kodwa ezimeleyo kwioksijini esebenzayo ukuveliswa kweentlobo. IBiochem Pharmacol 12-15-2002; 64: 1713-1724. Jonga i-abstract.
21. Kuo, P. L., Lin, T., kunye noLin, C. C. Umsebenzi we-antiproliferative we-aloe-emodin uhamba nge-p53-exhomekeke kwaye i-p21-exhomekeke kwindlela yeapoptotic kwimigca yeseli ye-hepatoma. Ubomi beSayensi 9-6-2002; 71: 1879-1892. Jonga i-abstract.
22. URosengren, uJ. E. no-Aberg, uT. Ukucocwa kwekholoni ngaphandle kwe-enemas. Imitha ye-1975; 15: 421-426. Jonga i-abstract.
23. UKoyama, J., Morita, I., Tagahara, K., Nobukuni, Y., Mukainaka, T., Kuchide, M., Tokuda, H., kunye noNishino, H. Chemopreventive Iziphumo zeemodin kunye necassiamin B kulusu lwempuku. icarcinogenesis. Umhlaza Lett 8-28-2002; 182: 135-139. Jonga i-abstract.
24. U-Lee, H. Z., Hsu, S. L., Liu, M. C., kunye noWu, C. H. Iziphumo kunye neendlela ze-aloe-emodin ekufeni kweseli kwimiphunga yomntu ye-squamous cell carcinoma. I-Eur J Pharmacol 11-23-2001; 431: 287-295. Jonga i-abstract.
25. U-Lee, H. Z. Protein kinase C ukubandakanyeka kwi-aloe-emodin- kunye ne-emodin-indased apoptosis kwiseli yemiphunga ye-carcinoma. UBr J Pharmacol 2001; 134: 1093-1103. Jonga i-abstract.
26. U-Lee, H. Z. Iziphumo kunye neendlela ze-emodin ekufeni kweseli kwindawo yomntu yemiphunga squamous cell carcinoma. UBr J Pharmacol 2001; 134: 11-20. Jonga i-abstract.
27. Muller, S. O., Eckert, I., Lutz, W. K., kunye no-Stopper, H. Genotoxicity yamachiza e-laxative emodin, i-aloe-emodin kunye ne-danthron kwiiseli ezanyisayo: i-topoisomerase II ilamlile? IMutat. IiRes 12-20-1996; 371 (3-4): 165-173. Jonga i-abstract.
28. ICascara sagrada, i-aloe laxatives, izinto zokucwangcisa ze-O-9 zodidi II-FDA. Iphepha leTan ngoMeyi 13, 2002.
29. Ukukhetha isisu sokuqunjelwa. Ileta ka-Pharmacist / I-Prescriber's Letter 2002; 18: 180614.
30. Ulawulo lokutya kunye neziyobisi, i-HHS. Ubume bezinto ezongezelelweyo ezingaphezulu kwekhawuntari yeziyobisi II kunye no-III. Umthetho wokugqibela. Ukubhaliswa kweFed 2002; 67: 31125-7. Jonga i-abstract.
31. UNadir A, uReddy D, uVan Thiel DH. ICascara-sagrada yenze ukuba i-cholestasis ye-intrahepatic ibangele uxinzelelo lwegazi kwi-portal: ingxelo yamatyala kunye nokuphononongwa kwe-herbal hepatotoxicity. NdinguJ Gastroenterol 2000; 95: 3634-7. Jonga i-abstract.
32. UNusko G, uSchneider B, uSchneider I, et al. Ukusetyenziswa kwe-anthranoid laxative ayisiyongxaki yomngcipheko we-colorectal neoplasia: iziphumo zophononongo olunokwenzeka lokulawulwa kwamatyala. Umjelo 2000; 46: 651-5. Jonga i-abstract.
33. I-DS encinci. Iziphumo zeziyobisi kuvavanyo lweelebhu zeklinikhi 4th ed. IWashington: I-AACC Press, ngo-1995.
34. ICovington TR, okqhubekayo. Incwadi yesandla yeziyobisi ezingabhaliswanga. Ngomhla we-11. IWashington, DC: Umbutho wamayeza waseMelika, ngo-1996.
35. Ukungqinisisa uBrinker F.Herb kunye nokuNxibelelana kweziyobisi. Ngomhla wesi-2. Isanti, OKANYE: Ushicilelo lwezoNyango lweEclectic, 1998.
36. UGruenwald J, uBrendler T, uJaenicke C. PDR wamaYeza eHerbal. Umhla woku-1. IMontvale, NJ: Inkampani yezoQoqosho kwezonyango, Inc., 1998.
37. Wichtl MW. Iziyobisi zeHerbal kunye nePhytopharmaceuticals. Umhleli. I-NM Bisset. I-Stuttgart: Abapapashi bezeNzululwazi beMedpharm GmbH, 1994.
38. Uphengululo lweeMveliso zeNdalo ngamaNqaku kunye nokuThelekisa. ILouis, MO: iWolters Kluwer Co., 1999.
39. INewall CA, uAnderson LA, uPhilpson JD. Unyango ngamayeza esintu: Isikhokelo saBasebenzi bezeMpilo. ILondon, e-UK: Icandelo leendaba lonyango, ngo-1996.
40. UTyler VE. IiHerbs zoKhetho. I-Binghamton, NY: Imveliso yezeMveliso yezeMveliso, ngo-1994.
41. Blumenthal M, ed. IKhomishini epheleleyo yaseJamani i-E Monographs: Isikhokelo sonyango kumaYeza eHerbal. Dlulisa. S. Klein. IBoston, MA: IBhunga laseMelika leBhotani, i-1998.
42. Monographs ekusebenziseni amayeza iziyobisi zezityalo. I-Exeter, e-UK: I-European Scientific Co-op Phytother, ngo-1997.

Ukuhlaziywa okokugqibela-09/09/2020